Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas

Cancer Research and Treatment : Official Journal of Korean Cancer Association
Seok Jin KimWon Seog Kim

Abstract

Pembrolizumab, a programmed cell death protein 1 (PD1) inhibitor inhibits the interplay between PD1 of T-cell and programmed cell death ligand 1 (PDL1) on tumor cells. Although pembrolizumab has been tried to various subtypes of non-Hodgkin lymphoma (NHL), realworld data about the efficacy of pembrolizumab in NHL patients are limited. We analyzed the outcome of 30 relapsed or refractory NHL patients treated with pembrolizumab, and compared the outcome between Epstein-Barr virus (EBV)‒positive and negative subtypes because EBV infection of tumor cells can upregulate PDL1 expression. Seven patients with EBV-positive NHL showed a response including NK/T-cell lymphoma (6/14, 44%) and primary mediastinal B-cell lymphoma (1/4, 25%) whereas EBV-negative subtypes did not respond such as diffuse large B-cell lymphoma and T-lymphoblastic lymphoma. We also evaluated PDL1 expression using tumor tissue of 76 patients. High PDL1 expression (positive staining of > 50% of tumor cells) was more frequent in NK/T-cell lymphoma and primary mediastinal B-cell lymphoma than other subtypes. Thus, PDL1 expression was significantly higher in EBV-positive (18/32, 56%) than EBV-negative NHL (4/38, 11%, p < 0.001). Furthermore, NK/T-cell lymphoma patients...Continue Reading

References

Mar 9, 2013·Nature Reviews. Immunology·Lieping Chen, Dallas B Flies
Apr 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivien MakKerry J Savage
May 16, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Benjamin J ChenScott J Rodig
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Margaretha G M RoemerMargaret A Shipp
Jun 23, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Charlotte RoachKarina Kulangara
Jun 30, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Philippe ArmandCraig H Moskowitz
Jul 31, 2016·Annals of Hematology·Thomas S Y ChanYok-Lam Kwong
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Nov 20, 2016·PloS One·Semir VranicZoran Gatalica
Apr 26, 2017·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Robert ChenUNKNOWN KEYNOTE-087

❮ Previous
Next ❯

Citations

Mar 13, 2020·Blood·Nader Kim El-Mallawany, Kenneth L McClain
Oct 28, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Junhun ChoWon Seog Kim
Jul 20, 2020·Journal of Neuro-oncology·Leon D KaulenJoachim M Baehring
Sep 13, 2020·Cancers·Yonggang PeiErle S Robertson
Jun 12, 2019·Journal of Hematology & Oncology·Peipei GaoPeng Wu
Aug 6, 2020·International Journal of Molecular Sciences·Ayumi KuzumeYosuke Minami
Jan 10, 2020·Blood Advances·Matthew J FrigaultRobin M Joyce
Aug 14, 2020·Journal of Hematology & Oncology·Basit SalikKyohei Nakamura
Dec 4, 2019·Applied Immunohistochemistry & Molecular Morphology : AIMM·Danielle L V MaracajaMina L Xu
Dec 3, 2020·Vaccines·Robert PytlikPavel Klener
Oct 31, 2020·International Journal of Molecular Sciences·Ji-Yoon NohHaiyoung Jung
Oct 27, 2020·Frontiers in Oncology·Polina ShindiapinaRobert A Baiocchi
Feb 11, 2021·Journal of Oncology·Guang-Liang ChenJunning Cao
Mar 20, 2021·Current Stem Cell Reports·Sandhya SharmaHelen E Heslop
Apr 20, 2021·La Revue de médecine interne·Y DieudonneA Guffroy
Jun 13, 2021·Leukemia·Hua WangYang Liang
Oct 29, 2021·International Journal of Laboratory Hematology·Lingyue XuHongzai Guan

❮ Previous
Next ❯

Methods Mentioned

BETA
biopsy

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

© 2022 Meta ULC. All rights reserved